Cargando…
FOXA1 Represses the Molecular Phenotype of Basal Breast Cancer Cells
Breast cancer is a heterogeneous disease comprised of multiple subtypes. Luminal subtype tumors confer a more favorable patient prognosis, which is in part, attributed to estrogen receptor-α (ER) positivity and anti-hormone responsiveness. Expression of the forkhead box transcription factor, FOXA1,...
Autores principales: | Bernardo, Gina M., Bebek, Gurkan, Ginther, Charles L., Sizemore, Steven T., Lozada, Kristen L., Miedler, John D., Anderson, Lee A., Godwin, Andrew K., Abdul-Karim, Fadi W., Slamon, Dennis J., Keri, Ruth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371315/ https://www.ncbi.nlm.nih.gov/pubmed/22391567 http://dx.doi.org/10.1038/onc.2012.62 |
Ejemplares similares
-
Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
por: Seachrist, Darcie D., et al.
Publicado: (2017) -
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
por: Seachrist, Darcie D., et al.
Publicado: (2021) -
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
por: Warrick, Joshua I., et al.
Publicado: (2022) -
Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs
por: Maier, Jennifer A., et al.
Publicado: (2013) -
FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer
por: Gong, C, et al.
Publicado: (2015)